CN103157082A - Medicament for treating herpes zoster - Google Patents
Medicament for treating herpes zoster Download PDFInfo
- Publication number
- CN103157082A CN103157082A CN 201310108644 CN201310108644A CN103157082A CN 103157082 A CN103157082 A CN 103157082A CN 201310108644 CN201310108644 CN 201310108644 CN 201310108644 A CN201310108644 A CN 201310108644A CN 103157082 A CN103157082 A CN 103157082A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- medicament
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a medicament for treating herpes zoster. The medicament is prepared from the following materials in parts by weight: 5 to 10 parts of figwort root, 10 to 20 parts of dried ginger, 20 to 30 parts of dogwood, 10 to 20 parts of platycodon grandiflorum, 15 to 25 parts of angelica dahurica, 5 to 15 parts of inula flower, 10 to 30 parts of cowherb seeds, 1 to 15 parts of dutchmanspipe vine, 10 to 20 parts of saposhnikovia divaricata, 15 to 30 parts of ephedra, 20 to 30 parts of terminaliae billericae, 1 to 20 parts of morinda officinalis, 1 to 20 parts of celandine, 10 to 25 parts of cogongrass rhizome, 10 to 30 parts of cocklebur fruit, 1 to 20 parts of emblic leafflower fruit, 15 to 20 parts of murraya paniculata, 10 to 20 parts of semen pharbitidis, 15 to 20 parts of inula herb, 15 to 30 parts of sarcandra glabra, 10 to 20 parts of clinopodium polycephalum, 10 to 25 parts of senna, 5 to 15 parts of aleppo avens, 1 to 20 parts of uniflower swisscentaury root, 15 to 25 parts of dahurian rhododendron leaf, 15 to 25 parts of potentilla disclor bunge, 10 to 20 parts of physalis permviana, 15 to 25 parts of coriolus versicolor, 20 to 30 parts of costus root, 1 to 20 parts of horsetail and 10 to 25 parts of fimbriae orostachys. All components of the medicament for treating the herpes zoster are natural materials, so the medicament is high in safety, definite in treatment effect and suitable for clinical large-scale popularization.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of herpes zoster.
Background technology
Herpes zoster is a kind of dermatosis that is caused by virus, and health any position can occur.Be apt to occur in the areal area of nervi trigeminus, nervi vertebralis, intercostal nerves and waist sacral nerves, because it invades nerve, patient's sufferings are in time treated particularly important unbearably.Herpes zoster belongs to " herpes zoster ", " skirt-roof dragon ", " Fructus Vitis viniferae stream " category.How because of feelings will internal injury, stagnation of QI due to depression of the liver, fire-transformation with the passing of time, the liver and gall fire is contained, and is subjected to poison evil and send out outward, and with purging liver and gallbladder, detoxification and promoting urination, reducing swelling and alleviating pain are the rule for the treatment of.These become the newtype drug basis of seeking the treatment herpes zoster.Completed on this basis the present invention.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of herpes zoster.
in order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of herpes zoster, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Coriolous Dersicolor (Fr.) Quel 15-25 part, Radix Aucklandiae 20-30 part, Herba Equiseti Hiemalis 1-20 part and Herba Orostachyos 10-25 part.
preferably, the medicament for the treatment of herpes zoster of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Coriolous Dersicolor (Fr.) Quel, 26 parts of the Radix Aucklandiae, 24 parts of 16 parts of Herba Equiseties Hiemalis and Herba Orostachyos.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of herpes zoster of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Further illustrate the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent in the present invention is percetage by weight.
Embodiment decoction of the present invention
take Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, the Radix Angelicae Dahuricae 21 grams, Flos Inulae 13 grams, Semen Vaccariae 28 grams, Herba Aristolochiae 11 grams, Radix Saposhnikoviae 17 grams, Herba Ephedrae 24 grams, Fructus Terminaliae Billericae 27 grams, Radix Morindae Officinalis 18 grams, Herba Chelidonii 17 grams, Rhizoma Imperatae 23 grams, Fructus Xanthii 21 grams, Fructus Phyllanthi 16 grams, Folium Et Cacumen Murrayae 16 grams, Semen Pharbitidis 17 grams, Herba Inulae 19 grams, Herba Sarcandrae 15 grams, Herba Clinopodii 14 grams, Folium Sennae 21 grams, Radix seu Herba Gei aleppici 11 grams, Radix Rhapontici 13 grams, Folium Rhododendri Daurici 23 grams, Herba Potentillae Discoloris 24 grams, Calyx Seu Fructus Physalis 14 grams, Coriolous Dersicolor (Fr.) Quel 25 grams, the Radix Aucklandiae 26 grams, Herba Equiseti Hiemalis's 16 grams and Herba Orostachyos 24 grams, add 4100 milliliters of entry, in being housed, heated 6 hours under 60 ℃ by the flask of condensing tube, filter.Filtrate is concentrated into 800 milliliters, namely gets decoction of the present invention.
Experimental example
Diagnostic criteria
Clinical diagnosis all meets the diagnostic criteria of " traditional Chinese medical science disease Standardization of diagnosis and curative effect " middle herpes zoster of State Administration of Traditional Chinese Medicine's issue.1. skin lesion mostly is the water scar of Semen phaseoli radiati or Semen Glycines size, assembles in threes and fours a place or many places, is arranged in band shape, and the substrate flushing is even the petechia can occur when serious, the blood scar is downright bad; 2. from the beginning of skin rubefaction, and companion's skin irritation or burning sensation, can be with slight heating, the General Symptomies such as tired discomfort, inappetence.Conscious pain is obvious, and unbearably severe pain and rear something lost pain symptom are arranged.
Choose patient's 40 examples that meet above-mentioned diagnostic criteria, wherein, male 20 examples, female's 20 examples, the oldest person is 60 years old, reckling is 28 years old, average 41 years old.
Use the decoction of preparation in embodiment 1 to treat, every day 2 times, each oral 50 milliliters.Treating 7 days is 1 course for the treatment of.
The observation of curative effect standard
" Chinese medicine card Standardization of diagnosis and curative effect " with reference to State Administration of Traditional Chinese Medicine's issue drafted.Recovery from illness: deflorescence, clinical symptom disappearance is without the pain sequela; Take a turn for the better: deflorescence approximately 50%, pain obviously alleviates; Do not heal: deflorescence less than 30% still has the pain malaise symptoms.
Therapeutic outcome
After treatment course for the treatment of, all patient's deflorescences, clinical symptom disappearance without the pain sequela, all meets the standard of recovery from illness, and in therapeutic process without any untoward reaction.
Claims (3)
1. medicament for the treatment of herpes zoster, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Coriolous Dersicolor (Fr.) Quel 15-25 part, Radix Aucklandiae 20-30 part, Herba Equiseti Hiemalis 1-20 part and Herba Orostachyos 10-25 part.
2. the medicament for the treatment of herpes zoster according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Coriolous Dersicolor (Fr.) Quel, 26 parts of the Radix Aucklandiae, 24 parts of 16 parts of Herba Equiseties Hiemalis and Herba Orostachyos.
3. the medicament for the treatment of herpes zoster according to claim 1, is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201310108644 CN103157082A (en) | 2013-03-22 | 2013-03-22 | Medicament for treating herpes zoster |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201310108644 CN103157082A (en) | 2013-03-22 | 2013-03-22 | Medicament for treating herpes zoster |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103157082A true CN103157082A (en) | 2013-06-19 |
Family
ID=48580947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201310108644 Pending CN103157082A (en) | 2013-03-22 | 2013-03-22 | Medicament for treating herpes zoster |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103157082A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111494488A (en) * | 2020-06-22 | 2020-08-07 | 成迎升 | External liquid medicament for treating herpes zoster |
-
2013
- 2013-03-22 CN CN 201310108644 patent/CN103157082A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111494488A (en) * | 2020-06-22 | 2020-08-07 | 成迎升 | External liquid medicament for treating herpes zoster |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101690745B (en) | Chinese medicinal composition for preventing and treating flu | |
| CN102166278B (en) | Chinese medicinal composition for treating pediatric rheumatoid arthritis and preparation method thereof | |
| CN101485837A (en) | Drug for treating cerebral infarction | |
| CN105535389A (en) | Traditional Chinese medicinal composition for treating lumbar and cervical bone hyperplasia and preparation method thereof | |
| CN104288328A (en) | Traditional Chinese medicinal composition for treating herpes zoster and preparation method thereof | |
| CN104306649B (en) | A kind of medicament for the treatment of herpes zoster | |
| CN103157082A (en) | Medicament for treating herpes zoster | |
| CN102526385B (en) | Medicament for treating climacteric syndrome | |
| CN103142958A (en) | Medicament for treating perniosis | |
| CN104825617A (en) | Traditional Chinese medicine for treating rheumatism bone disease and traditional Chinese medicine bag | |
| CN104274706A (en) | Traditional Chinese medicine mixture for treating radioactive stomatitis | |
| CN102488864B (en) | Medicinal composition for treating herpes zoster | |
| CN103157091A (en) | Drug for treating empyrosis | |
| CN104383158B (en) | A kind of Chinese medicine preparation for treating hip soft tissue's injury pain syndrome | |
| CN103157090A (en) | Medicament for treating diarrhea | |
| CN104013718A (en) | Field thistle decoction traditional Chinese medicine preparation | |
| CN103142972B (en) | Medicine for treating children dermatosis | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN102138991B (en) | Pharmaceutical composition for treating oral cancer and skin cancer | |
| CN101912566B (en) | Traditional Chinese medicine for treating palpitation | |
| CN103070998B (en) | Externally-applied plaster for curing pain of rheumatic joints | |
| CN103157081A (en) | Medicament for relaxing tendons and activating collaterals | |
| CN103356957B (en) | Medicine for treating stomach cancer and preparation method thereof | |
| CN103142960B (en) | Medicament for treating skin diseases | |
| CN103520541B (en) | Dressing umbilicus granule for treating postnatal neurosis intestinal obstruction and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130619 |